v3.25.1

Note to the cash flow statement

12 Months Ended

Dec. 31, 2024

Consolidated Statement of Cash Flows

Note to the cash flow statement

30. Note to the cash flow statement

​

​	​	​	​	​	​	​	​	​	​
​	​	December 31,
​		2024			2023			2022
​	​	(Euro, in thousands)
Adjustment for non-cash transactions	​	​	​	​	​	​	​	​	​
Depreciation and impairment on intangible assets and property, plant and equipment	​	€	45,499	​	€	43,642	​	€	65,566
Share-based compensation expenses	​	​	19,886	​	​	56,718	​	​	88,506
Increase/decrease (-) in retirement benefit obligations and provisions	​	​	(524)	​	​	11	​	​	136
Unrealized exchange losses/gains (-) and non-cash other financial result	​	​	(23,858)	​	​	19,908	​	​	(41,970)
Discounting effect of non-current deferred income	​	​	(227)	​	​	(645)	​	​	7,672
Discounting effect of other non-current liabilities	​	​	(395)	​	​	(318)	​	​	2,271
Discounting effect of contingent consideration receivable	​	​	(4,002)	​	​	—	​	​	—
Fair value re-measurement of warrants	​	​	(4)	​	​	(18)	​	​	(186)
Net change in fair value of current financial investments	​	​	(49,984)	​	​	(22,690)	​	​	(6,929)
Fair value adjustment financial assets held at fair value through profit or loss	​	​	—	​	​	390	​	​	—
Fair value adjustment contingent consideration receivable	​	​	(931)	​	​	—	​	​	—
Impairment loss on trade receivables	​	​	9,643	​	​	—	​	​	—
Other non-cash expenses	​	​	(12)	​	​	2,292	​	​	2,229
Total adjustment for non-cash transactions	​	€	(4,909)	​	€	99,291	​	€	117,296
​	​	​	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​	​	​
Adjustment for items to disclose separately under operating cash flow	​	​	​	​	​	​	​	​	​
Interest expense	​	€	912	​	€	1,867	​	€	6,967
Interest income	​	​	(89,378)	​	​	(79,319)	​	​	(14,344)
Income taxes	​	​	(1,705)	​	​	11,689	​	​	2,844
Correction for cash used for other liabilities related to the disposal of subsidiaries	​	​	527	​	​	—	​	​	—
Total adjustment for items to disclose separately under operating cash flow	​	€	(89,644)	​	€	(65,763)	​	€	(4,533)
​	​	​	​	​	​	​	​	​	​
Adjustment for items to disclose under investing and financing cash flows	​	​	​	​	​	​	​	​	​
Gain on disposal of subsidiaries	​	€	(52,488)	​	€	—	​	€	—
Gain (-)/loss on sale of fixed assets	​	​	8	​	​	(1,091)	​	​	(23)
Realized exchange gain on sale of current financial investments	​	​	—	​	​	—	​	​	—
Investment income related to financial investments	​	​	(23,759)	​	​	(15,597)	​	​	(3,766)
Total adjustment for items to disclose separately under investing and financing cash flow	​	€	(76,239)	​	€	(16,688)	​	€	(3,789)
​	​	​	​	​	​	​	​	​	​
Change in working capital other than deferred income	​	​	​	​	​	​	​	​	​
Increase (-)/ decrease in inventories	​	€	23,039	​	€	(24,076)	​	€	(34,588)
Increase (-)/ decrease in receivables	​	​	(31,055)	​	​	(39,114)	​	​	68,984
Increase/decrease (-) in liabilities	​	​	(53,429)	​	​	31,817	​	​	(2,083)
Total change in working capital other than deferred income	​	€	(61,445)	​	€	(31,373)	​	€	32,313

​

X

- Definition

The entire disclosure for a statement of cash flows.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 7
-IssueDate 2024-01-01
-Section Presentation of a statement of cash flows
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IAS07_g10-17_TI
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfCashFlowStatementExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_StatementOfCashFlowsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration